AAP
IDNA icon

Arax Advisory Partners’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Arax Advisory Partners’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-205
Closed -$4.84K – 4292
2025
Q3 		$4.84K Hold
205
– – ﹤0.01% 2877
2025
Q2 		$4.21K Buy
+205
New +$4.13K ﹤0.01% 2316

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Arax Advisory Partners's IDNA Position: Q4 2025 in Review

Arax Advisory Partners sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2025, closing a stake of 205 shares — an estimated $4.84K sold.

Arax Advisory Partners first reported a position in IDNA in Q2 2025 and held it in 2 quarters. The position peaked at $4.84K in Q3 2025. 58 funds tracked by Wall St. Rank hold IDNA as of Q4 2025.

  • Arax Advisory Partners reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2025 after selling out during the quarter.
  • Arax Advisory Partners sold 205 iShares Genomics Immunology and Healthcare ETF shares in Q4 2025, an estimated $4.84K.
  • Arax Advisory Partners first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2025 and held it in 2 quarters.
  • Arax Advisory Partners's iShares Genomics Immunology and Healthcare ETF position peaked at $4.84K in Q3 2025.
  • 58 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.